Ignite Creation Date:
2024-05-06 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05137795
Status:
WITHDRAWN
Last Update Posted:
2023-02-03
First Post:
2021-11-25
Brief Title:
Inhaled ZYESAMI Aviptadil Acetate for Treatment of Severe COVID-19
Sponsor:
APR Applied Pharma Research sa
Organization:
APR Applied Pharma Research sa
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-06-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-25
First Submit QC Date:
November 25 2021
Study First Post Date:
2021-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-02
Last Update Post Date:
2023-02-03
Last Update Post Date Type:
ACTUAL